Senolytic treatment for low back pain.

Matthew Mannarino, Hosni Cherif, Saber Ghazizadeh, Oliver Wu Martinez, Kai Sheng, Elsa Cousineau, Seunghwan Lee, Magali Millecamps, Chan Gao, Alice Gilbert, Cedric Peirs, Reza Sharif Naeini, Jean A Ouellet, Laura S Stone, Lisbet Haglund

Department of Surgery, Orthopaedic Research Lab, McGill University, Montreal, QC, Canada. · pubmed

Paper

Abstract

Senescent cells (SnCs) accumulate because of aging and external cellular stress throughout the body. They adopt a senescence-associated secretory phenotype (SASP) and release inflammatory and degenerative factors that actively contribute to age-related diseases, such as low back pain (LBP). The senolytics,

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that senolytic treatment can alleviate low back pain by targeting senescent cells and their inflammatory factors. This research addresses the root cause of aging-related diseases by exploring the potential of senolytics to improve health outcomes in age-related conditions.

Author of this paper? Send a correction.